Colon Cancer News and Research

Latest Colon Cancer News and Research

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen Ltd. announced today the discovery of more than ten novel targets of antibody therapy for various types of solid and hematopoietic cancer.

11 Jun 2008

The risk of death by age, sex, and smoking status in the U.S.

Researchers have updated charts that show an American's risk of dying from a given cause over the next ten years, based on age, sex, and smoking status. The charts will be published online June 10 in the Journal of the National Cancer Institute.

11 Jun 2008

Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s

The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

2 Jun 2008

New cancer stem cell identified behind metastatic tumors

The molecular profile of cancer stem cells that initiate metastatic colon tumors is significantly different from those responsible for primary tumors, according to new research from a team at Weill Cornell Medical College.

28 May 2008

Higher-risk people are shunning colon cancer screens

It is difficult to make colon cancer screening effective, according to a follow-up study conducted by the Swedish medical university Karolinska Institutet of a screening programme from 1999. Many of the people who would probably have benefited most from the survey opted not to take part.

25 May 2008

DNA modification seen in colorectal tumors helps predict outcomes, John Wayne Cancer Institute researchers find

An international study led by researchers at the John Wayne Cancer Institute at Saint John's Health Center has found that modifications to DNA found on multiple chromosomes in tumors can help to predict outcomes in patients with early-stage rectal cancer.

21 May 2008

Body mass index in adolescence in relation to cause-specific mortality

People who were already overweight in adolescence (14-19 years old) have an increased mortality rate from a range of chronic diseases as adults; endocrine, nutritional and metabolic diseases, cardiovascular diseases, colon cancer and respiratory diseases. There were also many cases of sudden death in this group. This comes from a new study from the Norwegian Institute of Public Health (NIPH).

20 May 2008

New understanding of colon tumor development

Recent work from the Finnish Academy Center of Excellence on Cancer Biology at the University of Helsinki, Finland, has shed light on the mechanisms of colon tumor development and may help to design better treatment for this disease.

5 May 2008

Epidermal growth factor receptor protects cancer cells from starving

A growth factor receptor found abundantly on the surface of cancer cells and long known to fuel cancer growth also protects tumor cells from starvation by a newly identified mechanism, researchers at The University of Texas M. D. Anderson Cancer Center report in the May 5 issue of Cancer Cell.

5 May 2008

AMPK signaling helps explain how cell growth is inhibited when nutrients are low

A team of scientists at the Salk Institute for Biological Studies think they know how many-if not most-living organisms answer this question. They recently showed that when food supplies dwindle, mammals, fruitflies, or frogs probably activate the same ancient cell signaling pathway in order to conserve energy.

24 Apr 2008

Discovery of new cell targets for preventing growth of breast and other tumors

Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.

23 Apr 2008

The limits of observational data in determining outcomes from cancer therapy

Certain biases may exist in observational studies that compare outcomes of different cancer therapies, making the results questionable.

21 Apr 2008

Inherited cancer gene mutation more common than formerly believed

A gene mutation responsible for the most common form of inherited colon cancer is older and more common than formerly believed, according to a recent study.

17 Apr 2008

An effective colon cancer prevention treatment

Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.

15 Apr 2008

Women's colon cancer risk perception associated with screening behavior

Women's perception of their cancer risk appears to vary by race and may affect how likely they are to undergo screenings, particularly for colon cancer, according to a report in the April 14 issue of Archives of Internal Medicine.

15 Apr 2008

Cancer prevention

Tapping into a growing body of knowledge about the origins and progression of cancer, researchers are now developing and testing new preventive therapies to stop it in its tracks.

15 Apr 2008

Targeted therapy combo overcomes treatment resistance in liver cancer

Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines.

13 Apr 2008

Targeted therapies overcome treatment resistance in liver cancer cell lines

Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines.

13 Apr 2008

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit presented findings showing that adding curcumin or resveratrol to conventional chemotherapy could be effective in preventing the growth of chemo-resistant colon cancer cells.

13 Apr 2008

What we eat and drink affects our risk of cancer

A healthy diet and lifestyle protect against a wide range of diseases, and new research presented at the American Association for Cancer Research 2008 Annual Meeting, April 12-16, shows that cancer is no exception.

13 Apr 2008

Colon Cancer News and Research

Latest Colon Cancer News and Research

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

The risk of death by age, sex, and smoking status in the U.S.

Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s

New cancer stem cell identified behind metastatic tumors

Higher-risk people are shunning colon cancer screens

DNA modification seen in colorectal tumors helps predict outcomes, John Wayne Cancer Institute researchers find

Body mass index in adolescence in relation to cause-specific mortality

New understanding of colon tumor development

Epidermal growth factor receptor protects cancer cells from starving

AMPK signaling helps explain how cell growth is inhibited when nutrients are low

Discovery of new cell targets for preventing growth of breast and other tumors

The limits of observational data in determining outcomes from cancer therapy

Inherited cancer gene mutation more common than formerly believed

An effective colon cancer prevention treatment

Women's colon cancer risk perception associated with screening behavior

Cancer prevention

Targeted therapy combo overcomes treatment resistance in liver cancer

Targeted therapies overcome treatment resistance in liver cancer cell lines

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

What we eat and drink affects our risk of cancer

Industry Focus eBook - Oncology (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Colon Cancer News and Research

Latest Colon Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in